Clinical Trials · NCT07755085

GLP-1s in Hip and Knee Arthroplasty

Not Yet RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Not Yet Recruiting
Sponsor
Nova Scotia Health Authority
Enrollment
100
Start date
Oct 2026
Locations
1 site, Canada
Primary endpoint
Incidence of Wound Complication after Joint Arthroplasty
View Semaglutide compound reference